IL17A and diabetes mellitus: Therefore, the present study indicated that EPE could ameliorate the incidence of type 1 diabetes mellitus and immunoregulation accompanied by a decrease in the number of CD4+ IL-17 cells and blood cytokine levels of IL-6 through the regulation of Th17 cells.